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Abstract
Muscle cramps are commonly observed in collegiate 
athlete-patients; however, the condition may be a 
symptom of severe disorders. In particular, idiopathic 
thrombocytopenic purpura (ITP) may be a possible 
diagnosis and involves a decreased number of platelets 
in the bloodstream. We describe a 21-year-old collegiate 
player of American football with initially presented with 
cramping of the neck, abdomen, and forearms. Although 
findings of physical examination were normal, results 
of laboratory tests indicated ITP, and the patient was 
hospitalized for 3 days until the platelet count increased. 
Because the levels continued to decrease at 6-month follow-
up, splenectomy and use of rituximab agents have been 
discussed with the patient for treatment after the end of 
the football season, before which dexamethasone will be 
administered to maintain a minimum platelet count of 50. 
Physicians should consider coordinating traditional care 
and specialist consultation to help treat severe conditions 
such as thrombocytopenia in athlete-patients. 
Introduction 
Muscle cramps are commonly seen in collegiate athlete-
patients. In performing differential diagnosis, muscle 
cramps can generate various potential causes of noted 
symptoms, ranging from simple to severe. In particular, 
findings of associated workup have revealed the presence 
of  idiopathic thrombocytopenic purpura (ITP), an 
autoimmune disorder characterized by the development 
of antibodies that reduce the amount of platelets in the 
bloodstream.1 The incidence rate in adults is estimated at 
about 1 in 10,000 patients per year in the United States.2 
Viral infections, medications, malignancy, autoimmune 
syndromes, and idiopathic features have been associated 
with the disorder.3 Bleeding has been rarely described 
with platelet counts of 10,000 or greater, and intracranial 
hemorrhage has been the most severe complication.3
Currently, no evidenced-based guidelines exist 
concerning the minimum platelet count required for 
athletes to participle in high-collision sports.3 We present 
a 21-year-old collegiate player of American football 
with ITP in whom initial hospitalization, followed by a 
tapering 10-week course of oral prednisone, and eventual 
administering of high-dose dexamethasone at 6-month 
follow-up led to temporarily normalized platelet counts but 
did not resolve reoccurrence of the decrease. Splenectomy 
or administration of rituximab agents has been discussed 
with the patient, who will resume competitive play with a 
minimum platelet count of 50 until the end of the football 
season and return after for treatment. 
Case Report
During preseason football training, a 21-year-old African 
American linebacker presented to our training room 
clinic with symptoms of cramping of the neck, abdomen, 
and forearms. He had a history of cramping after physical 
workouts but not in those locations. The patient also had 2 
days of rhinorrhea, sore throat, and cough. He expressed 
feeling weak, although no fevers, myalgias, and shortness of 
breath were noted. Adequate hydration was reported, with 
normal vital signs and findings of physical examination. 
Results of previous blood tests were negative for sickle 
cell trait, and no changes in urine had been noted. The 
patient had a history of possible Crohn’s disease diagnosed 
after a bout of diarrhea, with results of colonoscopy and 
biopsy indicating chronic inflammatory bowel disease 
of the previous year. The associated symptoms ultimately 
resolved. At the time of presentation to our institution, he 
had reported no diarrhea or gastrointestinal symptoms.
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Basic laboratory tests (ie, on complete blood count, 
complete metabolic panel, and levels of creatine kinase 
[CK]) were performed to rule out electrolyte disturbances 
and rhabdomyolysis. Findings showed a platelet count of 
38, creatinine count of 1.84, and elevated CK levels at 2591; 
otherwise, findings were normal. Further evaluation and 
laboratory tests were performed the next day, and results 
indicated that platelet and CK counts had changed to 21 
and 3915, respectively. Because findings had worsened, 
the patient was admitted to the hospital for monitoring 
symptoms and treatment. He was hospitalized for 3 days, 
during which a platelet count nadir (ie, lowest value) of 
14 was noted. The levels improved with administration of 
dexamethasone and intravenous fluids. Hematologists were 
subsequently consulted, and ITP and rhabdomyolysis were 
diagnosed. No symptoms were observed during the hospital 
stay of the patient, and he felt well at time of discharge. The 
mild rhabdomyolysis was thought to be caused by strength 
and conditioning workouts.
The patient missed 2 weeks total of preseason training 
and gradually returned to full participation after findings 
of laboratory tests had normalized (platelet count, 200). At 
about 10 days after discharge, however, the platelet count 
had decreased to 83. The patient was subsequently placed 
on a tapering 10-week course of prednisone. Hematologists 
recommended a platelet count of 100 or greater before 
resuming football-related activity.
At 6 months after his initial hospitalization, the patient 
was re-admitted to the hospital after a noted platelet count 
of 5, with upper respiratory viral illness. He was discharged 
at day 2, with promising results after being administered 
high-dose dexamethasone and a corresponding tapering 
course of prednisone. However, 2 weeks after cessation of 
prednisone tapering, the platelet count had dropped to 35. 
Subsequently, use of low-dose prednisone until undergoing 
eventual splenectomy or single-agent rituximab (suggested 
by hematologists) were discussed with the patient for 
treatment of ITP. 
The patient has been weighing treatment options and will 
make a definitive choice after the end of the football season. 
Until then, he will continue to participate in sports-related 
activity with a platelet count of 50 and greater, followed 
closely by our sports-medicine team and hematologists. 
Discussion 
ITP is a relatively common bleeding disorder, but currently 
no clear guidelines exists regarding return to play of athletes 
in high-collision sports. The American College of Sports 
Medicine has recommended to avoid contact-type sports 
with platelet counts of less than 100, although no significant 
clinical impact has been reported.4 The current case is one 
of the few to report findings of ITP in patient-athletes of 
high-collision sports. 
Several studies have described potential guidelines to 
follow in return to physical activity of patients with ITP, 
although no standard exists on athletes in high-collision 
sports. Two other case reports have reported ITP in patient-
athletes of high-collision sports.1,3 Specifically, Esala and 
Foy3 recommended a platelet count greater than 50 before 
participation in American football, supported by findings 
of an older study in which bleeding rarely occurred in 
counts of 50 or greater.5 Furthermore, current guidelines 
in obstetric patients have called for a target platelet count 
greater than 50 to minimize bleeding complications during 
childbirth.6 These suggestions have been helpful in treating 
ITP but do not consider athletes in high-collision sports 
and subsequent possibility of intracranial hemorrhage. 
The National Collegiate Athletic Association has not yet 
incorporated guidelines on minimum platelet count for safe 
participation. 
In the current case, a clear autoimmune link was not 
established between Crohn’s disease and intermittent ITP, 
despite a thorough evaluation. Glycogen storage diseases 
were also generated in differential diagnosis as possible 
causes of symptoms. Findings of extensive examinations 
such as electromyography, rheumatologic laboratory tests, 
and muscle biopsy were negative for a clear autoimmune 
cause. ITP, rhabdomyolysis, and Crohn’s disease were 
identified as separate processes without a clear autoimmune 
syndrome. 
Because symptoms of ITP were not resolved after 6 
months, we have discussed reportedly successful treatment 
options such as splenectomy7 with our patient and will 
closely follow him until a decision is made at the end of 
the football season. Until treatment, dexamethasone will 
be administered to maintain a minimum platelet count 
of 50. The findings of our study indicate that further 
research is required to determine platelet-count thresholds 
for safe participation of athletes in high-collision sports. 
Additionally, sports physicians should collaborate with 
other specialties when confronting cases such as ITP in 
which no substantial guidelines exist in directing treatment.
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Informed Consent
The patient was informed that the data concerning the case 
would be submitted for publication, and he provided verbal 
consent.
 
References
1. Leonard JC, Rieger M. Idiopathic thrombocytopenic 
purpura presenting in a high school football player: a case 
report. J Athl Train 1998;33(3):269-70.
2. Segal JB, Powe NR. Prevalence of immune 
thrombocytopenia: analyses of administrative data. J 
Thromb Haemost 2006;4(11):2377-83. 
3. Esala N, Foy P. A football player with thrombocytopenia. 
Curr Sports Med Rep 2015;14(1):47-8. 
4. McKeag DB, Moeller JL, eds. ACSM’s Primary Care 
Sports Medicine. 2nd ed. Philadelphia, PA: Lippincott 
Williams & Wilkins; 2007.
5. Lacey JV, Penner JA. Management of idiopathic 
thrombocytopenic purpura in the adult. Semin Thromb 
Hemost 1977;3(3):160-74. 
6. Webert KE, Mittal R, Sigouin C, Heddle NM, Kelton 
JG. A retrospective 11-year analysis of obstetric patients 
with idiopathic thrombocytopenic purpura. Blood 
2003;102(13):4306-11. 
7. Kubo N, Nishida J, Takagi S, et al. Preference of 
laparoscopic splenectomy over steroid therapy in a young 
field athlete with immune thrombocytopenic purpura. 
Intern Med 2002;41(8):674. 
UNM Orthopaedics Journal 2016
